Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells
2019 · Cancer Cell · 485 citations
https://doi.org/10.1016/j.ccell.2019.01.002
Y
Yu‐Hui Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
341
Papers
13.9K
Citations
50
h-index
149
i10-index
Yu‐Hui Chen is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Prostate Cancer Treatment and Research & CAR-T cell therapy research & Prostate Cancer Diagnosis and Treatment. The author has an h-index of 50, co-authored 290 publications.
ORCID: 0000-0003-4292-698XPapers by this author
worksGenomic adaptation to polyphagy and insecticides in a major East Asian noctuid pest
2017 · Nature Ecology & Evolution · 445 citations
https://doi.org/10.1038/s41559-017-0314-4
Immunological Synapse Predicts Effectiveness of Chimeric Antigen Receptor Cells
2018 · Molecular Therapy · 148 citations
https://doi.org/10.1016/j.ymthe.2018.01.020
Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial
2021 · Annals of Oncology · 73 citations
https://doi.org/10.1016/j.annonc.2021.06.003
Microinvasive Breast Cancer: ER, PR, and HER-2/neu Status and Clinical Outcomes after Breast-Conserving Therapy or Mastectomy
2012 · Annals of Surgical Oncology · 60 citations
https://doi.org/10.1245/s10434-012-2640-8
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020
2021 · Journal of Microbiology Immunology and Infection · 42 citations
https://doi.org/10.1016/j.jmii.2021.08.012
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat